Acorah Software Products - Accounts Production 16.3.350 false true false 29 September 2023 31 December 2024 31 December 2024 15174291 Anna Muñoz-Farré iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15174291 2023-09-28 15174291 2024-12-31 15174291 2023-09-29 2024-12-31 15174291 frs-core:CurrentFinancialInstruments 2024-12-31 15174291 frs-core:ComputerEquipment 2024-12-31 15174291 frs-core:ComputerEquipment 2023-09-29 2024-12-31 15174291 frs-core:ComputerEquipment 2023-09-28 15174291 frs-core:OtherReservesSubtotal 2024-12-31 15174291 frs-core:ShareCapital 2024-12-31 15174291 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 15174291 frs-bus:PrivateLimitedCompanyLtd 2023-09-29 2024-12-31 15174291 frs-bus:FilletedAccounts 2023-09-29 2024-12-31 15174291 frs-bus:SmallEntities 2023-09-29 2024-12-31 15174291 frs-bus:AuditExempt-NoAccountantsReport 2023-09-29 2024-12-31 15174291 frs-bus:SmallCompaniesRegimeForAccounts 2023-09-29 2024-12-31 15174291 frs-core:ListedExchangeTraded 2024-12-31 15174291 frs-core:ListedExchangeTraded 2023-09-28 15174291 frs-core:CostValuation frs-core:ListedExchangeTraded 2023-09-28 15174291 frs-core:AdditionsToInvestments frs-core:ListedExchangeTraded 2024-12-31 15174291 frs-core:CostValuation frs-core:ListedExchangeTraded 2024-12-31 15174291 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2023-09-28 15174291 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2024-12-31 15174291 frs-bus:Director1 2023-09-29 2024-12-31 15174291 frs-countries:EnglandWales 2023-09-29 2024-12-31 15174291 frs-core:Subsidiary1 2023-09-29 2024-12-31 15174291 frs-core:Subsidiary1 1 2023-09-29 2024-12-31
Registered number: 15174291
Punto Health Ltd
Unaudited Financial Statements
For the Period 29 September 2023 to 31 December 2024
Max Accountants Ltd
Ketton Suite
The King Centre
Oakham
Rutland
LE15 7WD
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—4
Page 1
Balance Sheet
Registered number: 15174291
31 December 2024
Notes £ £
FIXED ASSETS
Tangible Assets 4 7,576
Investments 5 2,518
10,094
CURRENT ASSETS
Debtors 6 1,533
Cash at bank and in hand 478,858
480,391
Creditors: Amounts Falling Due Within One Year 7 (10,736 )
NET CURRENT ASSETS (LIABILITIES) 469,655
TOTAL ASSETS LESS CURRENT LIABILITIES 479,749
NET ASSETS 479,749
CAPITAL AND RESERVES
Called up share capital 8 1
Other reserves 634,999
Profit and Loss Account (155,251 )
SHAREHOLDERS' FUNDS 479,749
For the period ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Anna Muñoz-Farré
Director
20 June 2025
The notes on pages 2 to 4 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Punto Health Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15174291 . The registered office is Health Foundry, 1 Royal Street, London, SE1 7LL.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
2.2. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 25% Straight line
2.3. Investments
Unlisted investments are recognised initially at cost and are reviewed annually for impairment. Subsequent to initial recognition, any changes in fair value are recognised in the profit and loss account.
2.4. Cash and Cash Equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts.
2.5. Financial Instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Basic financial assets
Basic financial assets, which include debtors and bank balances, are measured at transaction price including transaction costs.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, are recognised at transaction price including transaction costs.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities.
2.6. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
2.7. Research and Development
In the research phase of an internal project, it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives. 
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only. 
Page 2
Page 3
3. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
4. Tangible Assets
Computer Equipment
£
Cost
As at 29 September 2023 -
Additions 8,232
As at 31 December 2024 8,232
Depreciation
As at 29 September 2023 -
Provided during the period 656
As at 31 December 2024 656
Net Book Value
As at 31 December 2024 7,576
As at 29 September 2023 -
5. Investments
Listed
£
Cost
As at 29 September 2023 -
Additions 2,518
As at 31 December 2024 2,518
Provision
As at 29 September 2023 -
As at 31 December 2024 -
Net Book Value
As at 31 December 2024 2,518
As at 29 September 2023 -
Subsidiaries
Details of the company's subsidiaries as at 31 December 2024 are as follows:
Name of undertaking Registered Office Class of shares held Direct holding Indirect holding
Punto Clinic S.L. Spain Common Stock 100.00% -
Page 3
Page 4
6. Debtors
31 December 2024
£
Due within one year
Other debtors 1
VAT 1,532
1,533
7. Creditors: Amounts Falling Due Within One Year
31 December 2024
£
Other taxes and social security 5,454
Other creditors 4,532
Accruals and deferred income 750
10,736
8. Share Capital
31 December 2024
£
Allotted, Called up and fully paid 1
9. Reserves
Included within Other Reserves is £634,999 relating to funds received under Advanced Subscription Agreements. The funds were received prior to 31st December 2024 and are expected to be converted into equity in 2025.
Page 4